Skip to content

Clinical Performance Evaluation of Two Frequent Replacement Silicone Hydrogel Multifocal Toric Contact Lenses

Clinical Performance Evaluation of Two Frequent Replacement Silicone Hydrogel Multifocal Toric Contact Lenses

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06461455
Enrollment
95
Registered
2024-06-17
Start date
2024-07-26
Completion date
2024-12-31
Last updated
2025-12-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Astigmatism, Presbyopia

Keywords

Myopia, Hyperopia, Multifocal, Toric

Brief summary

The purpose of this study is to evaluate on-eye clinical performance of the investigational contact lenses following 30 days of wear in the intended population.

Detailed description

Subjects will wear two different contact lens study products in a cross-over fashion. Each study product type will be worn for approximately 30 days. A washout period of 2-4 days will occur prior to the first wear period and between the two wear periods. Subjects will be expected to attend 5 office visits. The total duration of study participation is approximately 66 days.

Interventions

DEVICELehfilcon A multifocal for astigmatism contact lenses

Investigational multifocal contact lenses for astigmatism

DEVICESamfilcon A multifocal for astigmatism contact lenses

Commercially available multifocal contact lenses for astigmatism

Hydrogen peroxide-based contact lens cleaning and disinfection system

Sponsors

Alcon Research
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Key Inclusion Criteria: * Habitual wearer of biweekly/monthly replacement soft multifocal or multifocal toric contact lenses in both eyes for a minimum of 5 days per week and 8 hours per day during the past 3 months; * Manifest cylinder equal to or greater than 0.75 diopter (D) in each eye at Screening; * Willing to not use readers while wearing study contact lenses for duration of the study; * Other protocol-defined inclusion criteria may apply. Key

Exclusion criteria

* Use of topical ocular medications and artificial tear or rewetting drops that would require instillation during contact lens wear; * Wears habitual contact lenses in an extended wear modality (routinely sleeping in lenses for at least 1 night per week) over the last 3 months prior to enrollment; * Monovision contact lens wearers and wearers of contact lens in one eye only; * Other protocol-defined

Design outcomes

Primary

MeasureTime frameDescription
Mean Binocular Visual Acuity at Distance (4 Meters) at Day 30 With Study LensesDay 30 (-2/+1) of each wear period. A wear period was 30 days (-2/+1) according to randomization assignment.Visual Acuity (VA) was assessed at a distance of 4 meters with both eyes together (binocular) under high contrast, high illumination lighting with study lenses in place. VA was measured using letter charts and recorded in the logarithm of the minimum angle of resolution (LogMAR). A LogMAR value of 0 equates to 20/20 Snellen VA (normal distance eyesight), with negative LogMAR values representing better than 20/20 VA. The LogMAR VA scale ranges from -0.30 (20/10 Snellen) to 1.00 (20/200 Snellen).

Countries

United States

Participant flow

Recruitment details

Subjects were enrolled at 11 investigative sites.

Pre-assignment details

Of the 95 enrolled, 6 subjects were discontinued as screen failures prior to randomization, and 4 subjects were discontinued post randomization and prior to exposure to the study lenses. This reporting group includes all subjects exposed to any study lenses evaluated in this study.

Participants by arm

ArmCount
LID230451, Then ULTRA MFfA
Lehfilcon A multifocal for astigmatism contact lenses worn in Period 1, followed by samfilcon A multifocal for astigmatism contact lenses worn in Period 2, as randomized. The study lenses were worn bilaterally (in both eyes) during typical contact lens wearing hours for at least 8 hours per day during each wear period \[30 days (-2/+1)\]. Study lenses were removed daily for cleaning and disinfection with CLEAR CARE.
46
ULTRA MFfA, Then LID230451
Samfilcon A multifocal for astigmatism contact lenses worn in Period 1, followed by lehfilcon A multifocal for astigmatism contact lenses worn in Period 2, as randomized. The study lenses were worn bilaterally (in both eyes) during typical contact lens wearing hours for at least 8 hours per day during each wear period \[30 days (-2/+1)\]. Study lenses were removed daily for cleaning and disinfection with CLEAR CARE.
39
Total85

Withdrawals & dropouts

PeriodReasonFG000FG001
First Wear Period (Approx 30 Days)Screen failure10
First Wear Period (Approx 30 Days)Withdrawal by Subject01
Washout Period (Approx 2-4 Days)Adverse Event01

Baseline characteristics

CharacteristicLID230451, Then ULTRA MFfAULTRA MFfA, Then LID230451Total
Age, Continuous55.8 years
STANDARD_DEVIATION 9.4
55.9 years
STANDARD_DEVIATION 9.4
55.9 years
STANDARD_DEVIATION 9.4
Race/Ethnicity, Customized
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race/Ethnicity, Customized
Asian
5 Participants10 Participants15 Participants
Race/Ethnicity, Customized
Black or African American
2 Participants2 Participants4 Participants
Race/Ethnicity, Customized
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race/Ethnicity, Customized
Other
0 Participants0 Participants0 Participants
Race/Ethnicity, Customized
White
39 Participants27 Participants66 Participants
Region of Enrollment
United States
46 participants39 participants85 participants
Sex: Female, Male
Female
29 Participants27 Participants56 Participants
Sex: Female, Male
Male
17 Participants12 Participants29 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
EG004
affected / at risk
deaths
Total, all-cause mortality
0 / 850 / 00 / 830 / 00 / 84
other
Total, other adverse events
0 / 850 / 1660 / 830 / 1680 / 84
serious
Total, serious adverse events
0 / 850 / 1660 / 830 / 1680 / 84

Outcome results

Primary

Mean Binocular Visual Acuity at Distance (4 Meters) at Day 30 With Study Lenses

Visual Acuity (VA) was assessed at a distance of 4 meters with both eyes together (binocular) under high contrast, high illumination lighting with study lenses in place. VA was measured using letter charts and recorded in the logarithm of the minimum angle of resolution (LogMAR). A LogMAR value of 0 equates to 20/20 Snellen VA (normal distance eyesight), with negative LogMAR values representing better than 20/20 VA. The LogMAR VA scale ranges from -0.30 (20/10 Snellen) to 1.00 (20/200 Snellen).

Time frame: Day 30 (-2/+1) of each wear period. A wear period was 30 days (-2/+1) according to randomization assignment.

Population: Full Analysis Set with data at visit

ArmMeasureValue (MEAN)Dispersion
LID230451Mean Binocular Visual Acuity at Distance (4 Meters) at Day 30 With Study Lenses-0.50 logMARStandard Deviation 0.1
ULTRA MFfAMean Binocular Visual Acuity at Distance (4 Meters) at Day 30 With Study Lenses-0.08 logMARStandard Deviation 0.09

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026